Stage IVA Thyroid Gland Follicular Carcinoma
specificStage IVA includes: (T4a, N0, M0); (T4a, N1a, M0); (T1, N1b, M0); (T2, N1b, M0); (T3, N1b, M0); (T4a, N1b, M0). T4a: Moderately advanced local disease. Tumor of any size extending beyond the thyroid gland capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve. T1: Tumor size 2 cm or less in greatest dimension, limited to the thyroid gland. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension, limited to the thyroid gland. T3: Tumor
5
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Stage IVA Thyroid Gland Follicular Carcinoma(5)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive | 60.0 |
| 2 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive | 60.0 |
| 3 | University of Illinois Cancer CenterChicago, IL | 60.0 |
| 4 | Boston University Cancer CenterBoston, MA | 60.0 |
| 5 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL | 60.0 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →